Dr. Surajit Das is a
distinguished leader with over two decades of extensive experience in Skin
& Personal Care, FMCGs/CPGs, Fragrance, Consumer Health, and Pharmaceutical
R&D. He has a proven track record of developing innovative products for
global markets, managing diverse teams, and driving business growth through
strategic initiatives. Currently, he serves as the Group Technical Operations
Manager at iNova Pharmaceuticals, where he leads global formulation and new
product development through contract research labs and external manufacturing
organizations. Dr. Das previously led R&D departments at Takasago,
significantly contributing to business growth in the APAC region. He has also
held pivotal roles at Procter & Gamble, A*STAR Institute of Chemical and
Engineering Sciences, and Sun Pharmaceutical. He holds a PhD in Pharmaceutics
from the National University of Singapore and an MBA from the University of
Nottingham. Recognized among the "World's Top 2% Scientists" by
researchers from Stanford University, his contributions are evidenced by
numerous research publications and patents. Additionally, Dr. Das is an
Associate Editor of Frontiers in Pharmacology and serves on the Editorial Board
of Recent Patents on Nanotechnology.
Dr. Surajit Das is a
distinguished leader with over two decades of extensive experience in Skin
& Personal Care, FMCGs/CPGs, Fragrance, Consumer Health, and Pharmaceutical
R&D. He has a proven track record of developing innovative products for
global markets, managing diverse teams, and driving business growth through
strategic initiatives. Currently, he serves as the Group Technical Operations
Manager at iNova Pharmaceuticals, where he leads global formulation and new
product development through contract research labs and external manufacturing
organizations. Dr. Das previously led R&D departments at Takasago,
significantly contributing to business growth in the APAC region. He has also
held pivotal roles at Procter & Gamble, A*STAR Institute of Chemical and
Engineering Sciences, and Sun Pharmaceutical. He holds a PhD in Pharmaceutics
from the National University of Singapore and an MBA from the University of
Nottingham. Recognized among the "World's Top 2% Scientists" by
researchers from Stanford University, his contributions are evidenced by
numerous research publications and patents. Additionally, Dr. Das is an
Associate Editor of Frontiers in Pharmacology and serves on the Editorial Board
of Recent Patents on Nanotechnology.